Suzanne Dahlberg

Alıntı yapanlar

	Hepsi	2019 yılından bugüne
Alıntılar	15143	8270
h-endeksi	66	48
i10-endeksi	112	92

1800

900

450

1350

2008200920102011201220132014201520162017201820192020202120222023202487 134 252 307 521 494 649 762 1036 1160 1205 1310 1654 1773 1605 1432 474

Genel erişim

Tümünü görüntüle

89 makale

2 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Geoffrey R. Oxnard, MDLoxo Oncology @ Lillyloxooncology.com üzerinde doğrulanmış e-posta adresine sahip
Donna NeubergDana-Farber Cancer Institutejimmy.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Lynette ShollBrigham and Women's Hospitalbwh.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Thomas LookProfessor of Pediatrics, Harvard Medical Schooldfci.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Heather WakeleeProfessor of Medicine, Stanford Universitystanford.edu üzerinde doğrulanmış e-posta adresine sahip
Sasha KravetsDivision of Epidemiology and Biostatistics, University of Illinois at Chicagouic.edu üzerinde doğrulanmış e-posta adresine sahip
Daniel Botelho CostaProfessor of Medicine | Harvard Medical School | Beth Israel Deaconess Medical Centerbidmc.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Leora HornVanderbilt Universityvumc.org üzerinde doğrulanmış e-posta adresine sahip
Uma AthaleProfessor, Pediatrics, McMaster Universitymcmaster.ca üzerinde doğrulanmış e-posta adresine sahip
Scott RodigProfessor of Pathology, Brigham & Women's Hospitalbwh.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Taofeek K. Owonikoko, MD/PhDUniversity of Pittsburghupmc.edu üzerinde doğrulanmış e-posta adresine sahip
Alejandro GutierrezBoston Children's Hospitalchildrens.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Robert GrayProfessor of Biostatistics, Havard School of Public Healthjimmy.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
steven schildmayo clinicmayo.edu üzerinde doğrulanmış e-posta adresine sahip
Charles RudinChief, Thoracic Oncology, Memorial Sloan Kettering Cancer Centermskcc.org üzerinde doğrulanmış e-posta adresine sahip
Natasha LeighlMedical Oncology, Princess Margaretuhn.ca üzerinde doğrulanmış e-posta adresine sahip
Matthew HellmannMemorial Sloan Kettering Cancer Centermskcc.org üzerinde doğrulanmış e-posta adresine sahip
Gabriel SicaUPMCupmc.edu üzerinde doğrulanmış e-posta adresine sahip
David P CarboneOhio State Universityosumc.edu üzerinde doğrulanmış e-posta adresine sahip
Jamie E. ChaftMemorial Sloan Kettering Cancer Centermskcc.org üzerinde doğrulanmış e-posta adresine sahip

Takip et

Suzanne Dahlberg

Associate Professor, Harvard Medical School, Boston Children's Hospital

childrens.harvard.edu üzerinde doğrulanmış e-posta adresine sahip

Biostatistics Clinical Trials Oncology Adolescent Medicine Pulmonology


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
MET exon 14 mutations in non–small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-Met overexpression MM Awad, GR Oxnard, DM Jackman, DO Savukoski, D Hall, P Shivdasani, ... Journal of clinical oncology, 2016	670	2016
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib GR Oxnard, Y Hu, KF Mileham, H Husain, DB Costa, P Tracy, N Feeney, ... JAMA oncology 4 (11), 1527-1534, 2018	608	2018
Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer AG Sacher, C Paweletz, SE Dahlberg, RS Alden, A O’Connell, N Feeney, ... JAMA oncology 2 (8), 1014-1022, 2016	608	2016
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia A Gutierrez, T Sanda, R Grebliunaite, A Carracedo, L Salmena, Y Ahn, ... Blood, The Journal of the American Society of Hematology 114 (3), 647-650, 2009	501	2009
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers D Rangachari, N Yamaguchi, PA VanderLaan, E Folch, A Mahadevan, ... Lung Cancer 88 (1), 108-111, 2015	464	2015
Outcomes for elderly, advanced-stage non–small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern … SS Ramalingam, SE Dahlberg, CJ Langer, R Gray, CP Belani, ... Journal of Clinical Oncology 26 (1), 60-65, 2008	458	2008
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes SE Lipshultz, TL Miller, RE Scully, SR Lipsitz, N Rifai, LB Silverman, ... Journal of clinical oncology 30 (10), 1042, 2012	364	2012
Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions GR Oxnard, PC Lo, M Nishino, SE Dahlberg, NI Lindeman, M Butaney, ... Journal of Thoracic Oncology 8 (2), 179-184, 2013	356	2013
Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs JJ Lin, S Cardarella, CA Lydon, SE Dahlberg, DM Jackman, PA Jänne, ... Journal of Thoracic Oncology 11 (4), 556-565, 2016	348	2016
Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia DJ DeAngelo, KE Stevenson, SE Dahlberg, LB Silverman, S Couban, ... Leukemia 29 (3), 526-534, 2015	326	2015
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute … LM Vrooman, KE Stevenson, JG Supko, J O'Brien, SE Dahlberg, ... Journal of Clinical Oncology 31 (9), 1202, 2013	325	2013
Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis A Mauguen, C Le Péchoux, MI Saunders, SE Schild, AT Turrisi, ... Journal of Clinical Oncology 30 (22), 2788, 2012	308	2012
Safety of programmed Death–1 pathway inhibitors among patients with Non–Small-Cell lung cancer and preexisting autoimmune disorders GC Leonardi, JF Gainor, M Altan, S Kravets, SE Dahlberg, L Gedmintas, ... Journal of Clinical Oncology 36 (19), 1905, 2018	303	2018
Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix AA Wright, BE Howitt, AP Myers, SE Dahlberg, E Palescandolo, ... Cancer 119 (21), 3776-3783, 2013	300	2013
Clinical course of advanced non–small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on … SE Dahlberg, AB Sandler, JR Brahmer, JH Schiller, DH Johnson Journal of Clinical Oncology 28 (6), 949, 2010	296	2010
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression EJ Aguilar, B Ricciuti, JF Gainor, KL Kehl, S Kravets, S Dahlberg, ... Annals of Oncology 30 (10), 1653-1659, 2019	268	2019
The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute … RF Grace, SE Dahlberg, D Neuberg, SE Sallan, JM Connors, EJ Neufeld, ... British journal of haematology 152 (4), 452-459, 2011	262	2011
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer A Calles, X Liao, LM Sholl, SJ Rodig, GJ Freeman, M Butaney, C Lydon, ... Journal of Thoracic Oncology 10 (12), 1726-1735, 2015	254	2015
Immune checkpoint inhibitor outcomes for patients with Non–Small-Cell lung cancer receiving baseline corticosteroids for palliative versus Nonpalliative indications B Ricciuti, SE Dahlberg, A Adeni, LM Sholl, M Nishino, MM Awad Journal of Clinical Oncology 37 (22), 1927-1934, 2019	246	2019
Single and dual targeting of mutant EGFR with an allosteric inhibitor C To, J Jang, T Chen, E Park, M Mushajiang, DJH De Clercq, M Xu, ... Cancer discovery 9 (7), 926-943, 2019	243	2019

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar